Brent Pfeiffenberger, President and Chief Executive Officer of Century Therapeutics, Inc. (NASDAQ:IPSC), reported a change in beneficial ownership of common stock on September 9, 2026, stemming from a transaction dated September 4, 2026.
Key Highlights
- Reporting person: Brent Pfeiffenberger, identified as President and CEO, and a Director of Century Therapeutics, Inc.
- Transaction date: September 4, 2026, with the filing submitted on September 9, 2026.
- Shares disposed: 463 shares of common stock were withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
- Price per share: $2.11, as stated in the filing.
- Resulting ownership: Following the transaction, Pfeiffenberger directly held 3,633,839 shares of common stock.
- Transaction code: F, indicating shares withheld for taxes, per the filing's explanation of responses.
Pfeiffenberger's RSU Vesting Triggers Tax-Related Share Withholding at Century Therapeutics
According to the filing, Brent Pfeiffenberger, who serves as President and Chief Executive Officer and is also a Director at Century Therapeutics, Inc., reported the disposition of 463 shares of common stock on September 4, 2026. The filing states that these shares were "withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units." The transaction was assigned code "F," consistent with shares withheld for tax purposes rather than an open-market sale.
Century Therapeutics, Inc. trades on NASDAQ under the symbol IPSC and is a clinical-stage biotechnology company, as indicated by its ticker symbol and the structure of its equity compensation. The shares were disposed of at a price of $2.11 each. No derivative securities transactions were reported in Table II of the filing. The filing was signed by Douglas Carr as Attorney-in-Fact on September 9, 2026, and indicates it was filed by one reporting person. Following the reported transaction, Pfeiffenberger's direct beneficial ownership stood at 3,633,839 shares of common stock, according to the filing.
What Was Disclosed
The filing reported the withholding of 463 shares of Century Therapeutics common stock at $2.11 per share from Brent Pfeiffenberger's holdings on September 4, 2026, to cover taxes upon restricted stock unit vesting, leaving him with 3,633,839 shares directly owned.






Please wait processing your request...